Ezutromid
Ezutromid (BMN 195) is a small molecule translation modulator of utrophin (EC50: 0.4 μM) that increases utrophin expression via transcriptional upregulation. This orally bioavailable compound has been shown to improve muscle function in the mdx mouse model of Duchenne muscular dystrophy through in vivo studies.
Product Specifications
CAS Number
945531-77-1
Product Name Alternative
Inhibitor, Ezutromid, metabolite, microsomes, liver, inhibit, muscular, dystrophy, Duchenne, benzoxazole, BMN 195, BMN195, BMN-195, SMT C 1100, SMT C1100, SMT C-1100, VOX-C 1100, VOX-C1100, VOX-C-1100
Field of Research
Metabolism Research
Purity
97.57% (May vary between batches)
Solubility
DMSO:12 mg/mL (35.57 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble)
Smiles
S (CC) (=O) (=O) C=1C=C2N=C (OC2=CC1) C3=CC4=C (C=C3) C=CC=C4
Molecular Formula
C19H15NO3S
Molecular Weight
337.39
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
